Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas

F Lefranc, V Facchini, R Kiss - The oncologist, 2007 - academic.oup.com
F Lefranc, V Facchini, R Kiss
The oncologist, 2007academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Describe the
pathways involved in the natural resistance of cancer cells to cytotoxic insults including radio-
/chemotherapy. Explain autophagic cell death as a potent alternative tumor-suppressing
mechanism. Identify the common targets in apoptosis and autophagy resistance pathways
and the surrogate markers that could be used in clinical practice for proautophagic therapy.
Discuss the rationale for incorporating endoplasmic reticulum stress inhibitors as adjuvant …
Learning Objectives
After completing this course, the reader will be able to:
  • Describe the pathways involved in the natural resistance of cancer cells to cytotoxic insults including radio-/chemotherapy.
  • Explain autophagic cell death as a potent alternative tumor-suppressing mechanism.
  • Identify the common targets in apoptosis and autophagy resistance pathways and the surrogate markers that could be used in clinical practice for proautophagic therapy.
  • Discuss the rationale for incorporating endoplasmic reticulum stress inhibitors as adjuvant chemotherapies against apoptosis-resistant cancers.
Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com
Oxford University Press